Published in World J Gastroenterol on August 14, 2013
Pancreatic cancer-improved care achievable. World J Gastroenterol (2014) 0.79
Quantification of diabetes comorbidity risks across life using nation-wide big claims data. PLoS Comput Biol (2015) 0.77
Risk Factors for Pancreatic Cancer in China: A Multicenter Case-Control Study. J Epidemiol (2015) 0.76
Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. Cent Eur J Immunol (2017) 0.75
Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study. PLoS One (2016) 0.75
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology (2011) 4.99
Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology (2009) 4.72
Abnormal glucose metabolism and pancreatic cancer mortality. JAMA (2000) 4.01
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA (1995) 3.83
Diabetes and the risk of pancreatic cancer. N Engl J Med (1994) 3.78
Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology (2007) 3.20
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology (2005) 2.60
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer (2011) 2.59
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol (2007) 2.40
Epidemiology of cancer of the pancreas. J Natl Cancer Inst (1973) 2.37
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer (2011) 2.30
A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25
Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control (1998) 2.04
Cancer mortality among diabetics. J Natl Cancer Inst (1970) 2.03
A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer (2003) 2.02
Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy. Pancreas (2003) 1.98
Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer (1989) 1.88
Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev (2006) 1.81
A case-control study of diabetes mellitus and cancer risk. Br J Cancer (1994) 1.76
Risk of cancer following hospitalization for type 2 diabetes. Oncologist (2010) 1.75
Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer (2005) 1.71
Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis (1985) 1.63
Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst (1995) 1.62
Diabetes and pancreatic carcinoma. Diabete Metab (1994) 1.59
Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen (2001) 1.59
A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer (2009) 1.56
Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control (1993) 1.49
Cancer of the pancreas. Available epidemiologic information and its implications. Cancer (1973) 1.47
Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev (1994) 1.39
Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol (2009) 1.37
Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study. PLoS One (2011) 1.31
Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer (1992) 1.31
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control (2010) 1.29
A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control (2002) 1.28
Factors influencing survival after total pancreatectomy in patients with pancreatic cancer. Ann Surg (1983) 1.27
Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis. Am J Gastroenterol (2012) 1.27
Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: findings from the Japan collaborative cohort study for evaluation of cancer risk. Int J Cancer (2002) 1.27
Clinical review 63: Diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab (1994) 1.25
Diabetes and pancreatic cancer: chicken or egg? Pancreas (2011) 1.23
A case control study of cancer of the pancreas. Cancer (1973) 1.23
Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer (2010) 1.23
Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study. Cancer Causes Control (2007) 1.22
An epidemiological evaluation of the causes of cancer of the pancreas. Cancer Res (1975) 1.21
Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas (2007) 1.21
The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev (2006) 1.20
Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol (1993) 1.19
Cancer and diabetes--a follow-up study of two population-based cohorts of diabetic patients. J Intern Med (1997) 1.15
New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol (2006) 1.14
Why do Black Americans have a higher risk of pancreatic cancer than White Americans? Epidemiology (2003) 1.13
Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer (2007) 1.11
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08
Geographic correlates of pancreas cancer in the United States. Cancer (1978) 1.05
Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan. Diabetes Care (2011) 1.01
Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas (2013) 1.00
Past medical history and pancreatic cancer risk: Results from a multicenter case-control study. Ann Epidemiol (2010) 0.99
The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer (2010) 0.99
Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall Study. Cancer Epidemiol Biomarkers Prev (2009) 0.98
Risk factors for pancreatic cancer in orientals. J Gastroenterol Hepatol (1996) 0.97
Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol (2009) 0.97
Epidemiologic characteristics and trace elements in pancreatic cancer in Greece. Cancer Detect Prev (1981) 0.97
Association between diagnosed diabetes and self-reported cancer among U.S. adults: findings from the 2009 Behavioral Risk Factor Surveillance System. Diabetes Care (2011) 0.97
Diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease? World J Surg (2001) 0.97
Diabetes, gall stone disease, and pancreatic cancer. Br J Cancer (1986) 0.97
A multi-institute case-control study on the risk factors of developing pancreatic cancer. Jpn J Clin Oncol (1992) 0.96
Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control (2011) 0.95
The association between carcinoma of the pancreas and diabetes mellitus. Br J Surg (1969) 0.95
Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden. Gut (2001) 0.93
A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer (2011) 0.93
Pancreatic cancer and diabetes: is there a relationship? A case-controlled study. Aust N Z J Surg (2000) 0.92
Diabetes mellitus, other medical conditions and pancreatic cancer: a case-control study. Diabetes Metab Res Rev (2011) 0.89
Cancer of the pancreas in Olmsted County, Minnesota, 1935-1974. Mayo Clin Proc (1979) 0.87
The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations. Int J Gastrointest Cancer (2006) 0.85
Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. Pancreas (2011) 0.83
Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study. BMC Med (2007) 0.82
Pancreatic cancer and diabetes mellitus. Diabet Med (1984) 0.81
Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China. J Dig Dis (2009) 0.81
Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis. Pancreas (2001) 0.80
Pancreatic ductal adenocarcinoma screening: new perspectives. World J Gastroenterol (2012) 0.79
Carcinoma of the pancreas. An analysis of 100 patients. Am J Gastroenterol (1967) 0.76
Family history of diabetes and pancreatic cancer. Pancreas (2005) 0.76
Risk factors and their identification. Third Part: Examples. Diabete Metab (1995) 0.76
Diabetes mellitus and carcinoma of the pancreas. Bull Soc Int Chir (1970) 0.76
Diabetes due to exocrine pancreatic disease--a review of patients attending a hospital-based diabetes clinic. QJM (2010) 0.75
First human case of esophagus-tracheal fistula closure by using a cardiac septal occluder (with video). Gastrointest Endosc (2010) 1.67
Successful closure of a postsurgical benign esophagomediastinal fistula by temporary placement of a polyester, expandable stent: Case report and review. Gastrointest Endosc (2002) 1.47
A predictive model identifies patients most likely to have inadequate bowel preparation for colonoscopy. Clin Gastroenterol Hepatol (2012) 1.42
WallFlex colonic stent placement for management of malignant colonic obstruction: a prospective study at two centers. Gastrointest Endosc (2008) 1.33
Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series. Gastrointest Endosc (2010) 1.33
Consensus guidelines on severe acute pancreatitis. Dig Liver Dis (2015) 1.12
Acute small-bowel perforation secondary to capsule endoscopy. Gastrointest Endosc (2007) 1.05
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. Eur J Immunol (2009) 1.01
Metal stents for malignant colorectal obstruction. Minim Invasive Ther Allied Technol (2006) 0.98
High efficacy of endoscopic submucosal dissection for rectal laterally spreading tumors larger than 3 cm. Gastrointest Endosc (2013) 0.97
Use of a colonoscope for distal duodenal stent placement in patients with malignant obstruction. Surg Endosc (2008) 0.93
Cytapheresis in inflammatory bowel diseases: current evidence and perspectives. Digestion (2008) 0.93
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. Am J Gastroenterol (2011) 0.92
Laparoscopic versus open distal pancreatectomy for ductal adenocarcinoma: a systematic review and meta-analysis. J Gastrointest Surg (2015) 0.92
A new regimen of bowel preparation for PillCam colon capsule endoscopy: a pilot study. Dig Liver Dis (2010) 0.92
Balanced propofol sedation administered by nonanesthesiologists: The first Italian experience. World J Gastroenterol (2011) 0.92
The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Gastrointest Endosc (2013) 0.91
A new metal stent with a controlled-release system for palliation of malignant dysphagia: a prospective, multicenter study. Gastrointest Endosc (2009) 0.90
Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance. Curr Med Chem (2007) 0.90
Endoscopic submucosal dissection of gastric neoplastic lesions in patients with liver cirrhosis: a systematic review. J Gastrointestin Liver Dis (2012) 0.87
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. World J Gastroenterol (2010) 0.84
Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 cases. Virchows Arch (2014) 0.83
Laparoscopic Distal Pancreatectomy in Benign or Premalignant Pancreatic Lesions: Is It Really More Cost-Effective than Open Approach? J Gastrointest Surg (2015) 0.80
Noncathartic CT colonography to screen for colorectal neoplasia in subjects with a family history of colorectal cancer. Radiology (2013) 0.79
The usefulness of a multidisciplinary team approach in decision making for pancreatic serous cystic neoplasms. JOP (2014) 0.75
Antioxidant treatment for acute pancreatitis. Recent Pat Inflamm Allergy Drug Discov (2014) 0.75
Endoscopic Ultrasonography May Select Subjects Having Asymptomatic Chronic Pancreatic Hyperenzymemia Who Require a Stricter Follow-up. Pancreas (2017) 0.75
Natural history of branch-duct intraductal papillary mucinous neoplasms of the pancreas: a case report. JOP (2014) 0.75
Benign Exocrine Pancreatic Diseases in Inflammatory Bowel Diseases. Dig Dis (2017) 0.75
Risk Factors for Malignancy of Branch-Duct Intraductal Papillary Mucinous Neoplasms: A Critical Evaluation of the Fukuoka Guidelines With a Systematic Review and Meta-analysis. Pancreas (2016) 0.75
Risk Factors for Malignancy of Branch-Duct Intraductal Papillary Mucinous Neoplasms: A Critical Evaluation of the Fukuoka Guidelines With a Systematic Review and Meta-analysis. Pancreas (2016) 0.75